> Intrac announced that a pivotal trial of Dyloject met its primary endpoint on pain relief. Release
> Nabi Biopharmaceuticals says that a mid-stage trial of its StaphVax vaccine showed that it helped boost antibodies in 90 percent of heart surgery patients. Story
> Shares of Aphton surged this morning after the biotech reported that a small Phase I trial of its experimental cancer treatment IGN311 demonstrated anti-tumor activity. Article
> Former McKesson CFO Richard Hawkins was found not guilty of fraud. Story
> Doctors have found that Lorenzo's Oil does indeed prevent a rare genetic disease. Story
And Finally... The Boston Globe looks at how doctors swiftly began to use Natrecor in outpatient clinics in a variety of ways that had never been tested for safety. Article